Treatment of acute intracerebral haemorrhage with a Chinese herbal formula (Shengdi Dahuang Decoction): a multicentre, double-blind, randomised, placebo-controlled trial

作者
Zhihuan Sun,Xiaoyu Zhou,Jingyan Xiang,Feng Wang,Yan Han,Yongmei Guo,Zongqi Zhang,Fan Gong,Mingzhe Wang,Dezhi Liu,Weidong Pan,Haiyan Tang,Tingting Li,Jingsi Zhang,Shan Jiang,Jihan Huang,Xiaofei Yu
出处
期刊:Stroke and vascular neurology [BMJ]
卷期号:11 (2): svn-2024 被引量:2
标识
DOI:10.1136/svn-2024-003931
摘要

IMPORTANCE: Per preliminary studies, Shengdi Dahuang Decoction (SDD) is potentially effective for acute intracerebral haemorrhage (ICH); however, its effectiveness has not been rigorously assessed in extensive randomised clinical trials. OBJECTIVE: To evaluate whether SDD can improve 90-day functional outcomes in patients with ICH. DESIGN: Randomised, double-blind, placebo-controlled clinical trial included patients with acute ICH within 4 hours of symptom onset at five hospitals in Shanghai, China. INTERVENTIONS: and 5 g of raw rhubarb) or placebo granules orally or via a nasogastric tube (as soon as possible within 12 hours of onset, two times daily for 7 days), in addition to ICH guideline-directed treatments. Per our preclinical study, SDD reduces inflammatory injury after ICH in rats. MAIN OUTCOMES: The primary outcome measure was the proportion of patients with a score ranging 0-1 on the modified Rankin Scale (mRS) on the 90th day. RESULTS: Of the total 1211 participants with cerebral haemorrhage assessed for eligibility, 483 were enrolled. Of this, 242 participants were randomly assigned to receive SDD granules and 241 to receive placebo granules (mean age, 62.7 years; 72.9% male). Among these, 112 (46.3%) and 84 (34.9%) patients in the SDD and placebo groups, respectively, had an mRS score of 0-1 on the 90th day (adjusted relative risk 1.20, 95% CI 1.00 to 1.43; p=0.046) . The proportion of patients with poor clinical outcomes (mRS score of 5 or 6 at 90 days) was higher in the placebo group (11.2%) than in the SDD group (5.4%) (p=0.021). The 90-day mortality rate (p=0.299), 7-day National Institute of Health Stroke Scale score (p=0.583), 7-day Glasgow Coma Scale score (p=0.577), 24-hour haematoma enlargement rate (p=0.675) or 7-day relative perihaematomal oedema did not significantly differ (p=0.343) between the groups. The incidence of adverse events between the two groups did not differ significantly (p>0.05). CONCLUSIONS: In patients with acute ICH, incorporating SDD as a supplementary intervention alongside guideline-directed treatments may help enhance 90-day functional outcomes; however, more clinical trials are required to further prove its efficacy. TRIAL REGISTRATION NUMBER: NCT04200781.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
寒冷乐双发布了新的文献求助10
刚刚
1秒前
1秒前
1秒前
Willing发布了新的文献求助10
1秒前
2秒前
飞飞完成签到,获得积分10
2秒前
xx关闭了xx的文献求助
2秒前
李铮完成签到,获得积分10
3秒前
3秒前
秋风的应助被跳跃的颦采纳,获得10
3秒前
Martin完成签到,获得积分10
3秒前
3秒前
鲤鱼听荷完成签到 ,获得积分10
3秒前
英俊的铭的应助被偏执苦楚采纳,获得10
3秒前
zcq完成签到 ,获得积分10
3秒前
3秒前
4秒前
珊珊发布了新的文献求助10
4秒前
olivia发布了新的文献求助10
4秒前
4秒前
zhangxinyan发布了新的文献求助10
5秒前
kkkkkk发布了新的文献求助10
5秒前
亚李发布了新的文献求助10
6秒前
zh4n96y完成签到,获得积分20
6秒前
7秒前
Marina完成签到 ,获得积分10
7秒前
慕青的应助被zmrright采纳,获得10
7秒前
7秒前
飞行雪绒发布了新的文献求助10
8秒前
深情安青的应助被初景采纳,获得10
8秒前
8秒前
冥土追魂发布了新的文献求助10
8秒前
周姮媛发布了新的文献求助10
9秒前
9秒前
h11的应助被欧皇采纳,获得10
9秒前
JamesPei的应助被ydygdy采纳,获得10
9秒前
sunnymoon发布了新的文献求助10
9秒前
汉堡包的应助被Willing采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047